Ozoralizumab (ATN-103) is a humanized anti-TNFalpha antibody and a novel TNFalpha inhibitor.Ozoralizumab binds human serum albumin and can be used to study rheumatoid arthritis.
Purity:
95.60%
CAS Number:
[1167985-17-2]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted